Company Announcements In June, LifeSpan BioScience announced plans to release 20,000 immunohistochemistry-validated reagent antibodies over the next four years. It currently offers 37,000 reagent antibodies. Embryome Sciences entered into a manufacturing and distribution agreement with Lifeline Cell Technology to produce standardized human and animal progenitor cell lines and corresponding reagents. Embryome Sciences acquired an exclusive […]
Company Announcements In May, Invitrogen licensed human embryonic stem cell (hESC) patents from the Wisconsin Alumni Research Foundation for the development of research tools, giving it the right to work with karyotypically normal hESCs. Agilent acquired a license in May from the Broad Institute to commercialize a method for genome partitioning using Agilent’s Oligo Library […]
Company Announcements Takara Biotech opened a manufacturing facility for Clontech products in Dalian, China, earlier this year. LGC Standards will commercialize Abcellute’s hepatocyte preservation technology. Lentigen exclusively licensed fundamental lentiviral vector technology from the University of Cambridge. Invitrogen named Germany-based imaGenes as its European distributor for Gateway full ORF clones. Invitrogen was named the exclusive […]
Madison, WI 5/30/08—Molecular diagnostics company Third Wave Technologies has agreed to acquire Stratagene’s Full Velocity patents and patent applications from Agilent Technologies. The Full Velocity patents cover quantitative PCR and quantitative real-time PCR chemistries. “Third Wave’s strategic acquisition of the Full Velocity patents cements an integral part of our clinical menu expansion plans and provides […]
Company Announcements New Zealand–based ZyGEM, a provider of enzyme-based reagents, opened its US headquarters in Solana Beach, California, in January. Invitrogen was named the exclusive provider of fluorescent miRNA microarray labeling kits using Genispheres’ 3DNA dendrimer signal amplification technology. Sigma-Aldrich and MorphoSys AG will design, produce and distribute unique recombinant antibodies. In February, Exiqon A/S […]
Company Announcements Luminex and Tyson Foods are collaborating to develop food-safety and animal-health tests. In February, Invitrogen expanded its license and supply agreement with Luminex, extending the lifetime of the license and providing it with access to next-generation multiplex detection platforms. Invitrogen offers more than 200 assays based on Luminex’s xMAP Technology. In February, Sigma-Aldrich […]
Company Announcements Eurofins acquired Operon Biotechnologies in late 2007 and consolidated the company’s operations with Eurofins MWG and Eurofins Medigenomix for custom oligonucleotide synthesis services. In total, the three operations generate $50 million in revenues. Under a three-year research, supply and marketing agreement, Berry & Associates and Luminos will develop designer reagents to enable luminescent […]
St. Louis, MO 3/7/08—Sigma-Aldrich and Oxford Biomedica have settled their patent litigation against Open Biosystems (see IBO 6/15/06). Under the confidential settlement, Open Biosystems will acquire certain license rights for use of Oxford BioMedica’s LentiVector gene delivery technology in research activities. Other details were not disclosed.
Abeome granted Millipore an exclusive worldwide license to market and distribute the Human Embryonic Stem Cell Antigen-1 antibody for research use. In December 2007, EMD Chemicals’ Novagen brand licensed Luminex’s xMAP Technology platform in order to develop immunoassays for it. Rules-Based Medicine granted EMD Chemicals exclusive distribution rights to its quantitative protein multiplex assays, and […]
Luminex launched the FlexmiR Select miRNA Select assay for the creation of customized RNA panels. Genetix released CloneMedia-HEK and CloneMedia-CHOK1. Millipore announced the “Stem Cell Tested” Initiative to ensure that many of its filter products are validated for use on stem cells, starting with the Stericup with Express PLUS membrane. Millipore launched its Tyrosine Kinases […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
